{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T00:38:05Z","timestamp":1783471085720,"version":"3.55.0"},"reference-count":98,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,1,28]],"date-time":"2015-01-28T00:00:00Z","timestamp":1422403200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["World J Pediatr"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1007\/s12519-015-0003-9","type":"journal-article","created":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T03:41:58Z","timestamp":1422330118000},"page":"21-28","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":38,"title":["Pathogenesis of childhood idiopathic nephrotic syndrome: a paradigm shift from T-cells to podocytes"],"prefix":"10.1007","volume":"11","author":[{"given":"Kazunari","family":"Kaneko","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoji","family":"Tsuji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kimata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuya","family":"Kitao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sohsaku","family":"Yamanouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shogo","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,1,28]]},"reference":[{"key":"3_CR1","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/kisup.2012.16","volume":"2","author":"KDIGO.","year":"2012","unstructured":"KDIGO. Chapter 3: Steroid-sensitive nephrotic syndrome in children. Kidney Int Suppl (2011) 2012;2:163\u2013171.","journal-title":"Kidney Int Suppl (2011)"},{"key":"3_CR2","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S0140-6736(03)14184-0","volume":"362","author":"AA Eddy","year":"2003","unstructured":"Eddy AA, Symons JM. Nephrotic syndrome in childhood. Lancet 2003;362:629\u2013639.","journal-title":"Lancet"},{"key":"3_CR3","doi-asserted-by":"crossref","first-page":"56","DOI":"10.2174\/157339609787587537","volume":"5","author":"K Kaneko","year":"2009","unstructured":"Kaneko K. Pathogenesis in childhood idiopathic nephrotic syndrome: an update of patchwork. Curr Pediatr Rev 2009;5:56\u201364.","journal-title":"Curr Pediatr Rev"},{"key":"3_CR4","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/adc.71.6.522","volume":"71","author":"TJ Neuhaus","year":"1994","unstructured":"Neuhaus TJ, Fay J, Dillon MJ, Trompeter RS, Barratt TM. Alternative treatment to corticosteroids in steroid sensitive idiopathic nephrotic syndrome. Arch Dis Child 1994;71:522\u2013526.","journal-title":"Arch Dis Child"},{"key":"3_CR5","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1159\/000045609","volume":"84","author":"H Ahmad","year":"2000","unstructured":"Ahmad H, Tejani A. Predictive value of repeat renal biopsies in children with nephrotic syndrome. Nephron 2000;84:342\u2013346.","journal-title":"Nephron"},{"key":"3_CR6","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00467-007-0633-9","volume":"24","author":"H Jalanko","year":"2009","unstructured":"Jalanko H. Congenital nephrotic syndrome. Pediatr Nephrol 2009;24:2121\u20132128.","journal-title":"Pediatr Nephrol"},{"key":"3_CR7","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S0140-6736(74)91880-7","volume":"2","author":"RJ Shalhoub","year":"1974","unstructured":"Shalhoub RJ. Pathogenesis of lipoid nephrosis: a disorder of T-cell function. Lancet 1974;2:556\u2013560.","journal-title":"Lancet"},{"key":"3_CR8","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1097\/00007890-199410000-00018","volume":"58","author":"AA Ali","year":"1994","unstructured":"Ali AA, Wilson E, Moorhead JF, Amlot P, Abdulla A, Fernando ON, et al. Minimal-change glomerular nephritis. Normal kidneys in an abnormal environment? Transplantation 1994;58:849\u2013852.","journal-title":"Transplantation"},{"key":"3_CR9","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S0022-3476(79)80665-4","volume":"95","author":"SM Mauer","year":"1979","unstructured":"Mauer SM, Hellerstein S, Cohn RA, Sibley RK, Vernier RL. Recurrence of steroid-responsive nephrotic syndrome after renal transplantation. J Pediatr 1979;95:261\u2013264.","journal-title":"J Pediatr"},{"key":"3_CR10","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00467-010-1700-1","volume":"26","author":"F Assadi","year":"2011","unstructured":"Assadi F. Neonatal nephrotic syndrome associated with placental transmission of proinflammatory cytokines. Pediatr Nephrol 2011;26:469\u2013471.","journal-title":"Pediatr Nephrol"},{"key":"3_CR11","doi-asserted-by":"crossref","first-page":"423","DOI":"10.5414\/CNP65423","volume":"65","author":"T Kobayashi","year":"2006","unstructured":"Kobayashi T, Ando Y, Umino T, Miyata Y, Muto S, Hironaka M, et al. Complete remission of minimal-change nephrotic syndrome induced by apheresis monotherapy. Clin Nephrol 2006;65:423\u2013426.","journal-title":"Clin Nephrol"},{"key":"3_CR12","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1038\/ki.1991.232","volume":"40","author":"A Koyama","year":"1991","unstructured":"Koyama A, Fujisaki M, Kobayashi M, Igarashi M, Narita M. A glomerular permeability factor produced by human T cell hybridomas. Kidney Int 1991;40:453\u2013460.","journal-title":"Kidney Int"},{"key":"3_CR13","first-page":"289","volume":"47","author":"V Daniel","year":"1997","unstructured":"Daniel V, Trautmann Y, Konrad M, Nayir A, Sch\u00e4rer K. T-lymphocyte populations, cytokines and other growth factors in serum and urine of children with idiopathic nephrotic syndrome. Clin Nephrol 1997;47:289\u2013297.","journal-title":"Clin Nephrol"},{"key":"3_CR14","first-page":"177","volume":"37","author":"M Mandreoli","year":"1992","unstructured":"Mandreoli M, Beltrandi E, Casadei-Maldini M, Mancini R, Zucchelli A, Zucchelli P. Lymphocyte release of soluble IL-2 receptors in patients with minimal change nephropathy. Clin Nephrol 1992;37:177\u2013182.","journal-title":"Clin Nephrol"},{"key":"3_CR15","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1007\/BF00865458","volume":"8","author":"SA Hulton","year":"1994","unstructured":"Hulton SA, Shah V, Byrne MR, Morgan G, Barratt TM, Dillon MJ. Lymphocyte subpopulations, interleukin-2 and interleukin-2 receptor expression in childhood nephrotic syndrome. Pediatr Nephrol 1994;8:135\u2013139.","journal-title":"Pediatr Nephrol"},{"key":"3_CR16","doi-asserted-by":"crossref","first-page":"242","DOI":"10.5414\/CNP60242","volume":"60","author":"MJ Kemper","year":"2003","unstructured":"Kemper MJ, Meyer-Jark T, Lilova M, Muller-Wiefel DE. Combined T- and B-cell activation in childhood steroid-sensitive nephrotic syndrome. Clin Nephrol 2003;60:242\u2013247.","journal-title":"Clin Nephrol"},{"key":"3_CR17","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1111\/j.1365-2249.1995.tb03725.x","volume":"100","author":"TJ Neuhaus","year":"1995","unstructured":"Neuhaus TJ, Wadhwa M, Callard R, Barratt TM. Increased IL-2, IL-4 and interferon-gamma (IFN-gamma) in steroid-sensitive nephrotic syndrome. Clin Exp Immunol 1995;100:475\u2013479.","journal-title":"Clin Exp Immunol"},{"key":"3_CR18","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s004670050592","volume":"13","author":"BS Cho","year":"1999","unstructured":"Cho BS, Yoon SR, Jang JY, Pyun KH, Lee CE. Up-regulation of interleukin-4 and CD23\/FcepsilonRII in minimal change nephrotic syndrome. Pediatr Nephrol 1999;13:199\u2013204.","journal-title":"Pediatr Nephrol"},{"key":"3_CR19","first-page":"77","volume":"45","author":"CY Lin","year":"2004","unstructured":"Lin CY, Chien JW. Increased interleukin-12 release from peripheral blood mononuclear cells in nephrotic phase of minimal change nephrotic syndrome. Acta Paediatr Taiwan 2004;45:77\u201380.","journal-title":"Acta Paediatr Taiwan"},{"key":"3_CR20","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1159\/000046017","volume":"88","author":"K Matsumoto","year":"2001","unstructured":"Matsumoto K, Kanmatsuse K. Elevated interleukin-18 levels in the urine of nephrotic patients. Nephron 2001;88:334\u2013339.","journal-title":"Nephron"},{"key":"3_CR21","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0272-6386(12)80742-6","volume":"21","author":"MG Suranyi","year":"1993","unstructured":"Suranyi MG, Guasch A, Hall BM, Myers BD. Elevated levels of tumor necrosis factor-alpha in the nephrotic syndrome in humans. Am J Kidney Dis 1993;21:251\u2013259.","journal-title":"Am J Kidney Dis"},{"key":"3_CR22","first-page":"269","volume":"55","author":"K Matsumoto","year":"2001","unstructured":"Matsumoto K, Kanmatsuse K. Elevated vascular endothelial growth factor levels in the urine of patients with minimal-change nephrotic syndrome. Clin Nephrol 2001;55:269\u2013274.","journal-title":"Clin Nephrol"},{"key":"3_CR23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000187441","volume":"65","author":"S Saxena","year":"1993","unstructured":"Saxena S, Mittal A, Andal A. Pattern of interleukins in minimalchange nephrotic syndrome of childhood. Nephron 1993;65:56\u201361.","journal-title":"Nephron"},{"key":"3_CR24","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1007\/PL00013437","volume":"14","author":"J Stachowski","year":"2000","unstructured":"Stachowski J, Barth C, Michalkiewicz J, Krynicki T, Jarmolinski T, Runowski D, et al. Th1\/Th2 balance and CD45-positive T cell subsets in primary nephrotic syndrome. Pediatr Nephrol 2000;14:779\u2013785.","journal-title":"Pediatr Nephrol"},{"key":"3_CR25","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1046\/j.1365-2249.1999.00975.x","volume":"117","author":"K Matsumoto","year":"1999","unstructured":"Matsumoto K, Kanmatsuse K. Increased IL-12 release by monocytes in nephrotic patients. Clin Exp Immunol 1999;117:361\u2013367.","journal-title":"Clin Exp Immunol"},{"key":"3_CR26","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1111\/j.1365-2362.1994.tb02022.x","volume":"24","author":"C Bustos","year":"1994","unstructured":"Bustos C, Gonzalez E, Muley R, Alonso JL, Egido J. Increase of tumour necrosis factor alpha synthesis and gene expression in peripheral blood mononuclear cells of children with idiopathic nephrotic syndrome. Eur J Clin Invest 1994;24:799\u2013805.","journal-title":"Eur J Clin Invest"},{"key":"3_CR27","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1681\/ASN.V103529","volume":"10","author":"HK Yap","year":"1999","unstructured":"Yap HK, Cheung W, Murugasu B, Sim SK, Seah CC, Jordan SC. Th1 and Th2 cytokine mRNA profiles in childhood nephrotic syndrome: evidence for increased IL-13 mRNA expression in relapse. J Am Soc Nephrol 1999;10:529\u2013537.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR28","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1046\/j.1523-1755.1999.0550031063.x","volume":"55","author":"NJ Webb","year":"1999","unstructured":"Webb NJ, Watson CJ, Roberts IS, Bottomley MJ, Jones CA, Lewis MA, et al. Circulating vascular endothelial growth factor is not increased during relapses of steroid-sensitive nephrotic syndrome. Kidney Int 1999;55:1063\u20131071.","journal-title":"Kidney Int"},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s00467-005-2078-3","volume":"21","author":"PF Laflam","year":"2006","unstructured":"Laflam PF, Garin EH. Effect of tumor necrosis factor alpha and vascular permeability growth factor on albuminuria in rats. Pediatr Nephrol 2006;21:177\u2013181.","journal-title":"Pediatr Nephrol"},{"key":"3_CR30","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1681\/ASN.2006070710","volume":"18","author":"KW Lai","year":"2007","unstructured":"Lai KW, Wei CL, Tan LK, Tan PH, Chiang GS, Lee CG, et al. Overexpression of interleukin-13 induces minimal-change-like nephropathy in rats. J Am Soc Nephrol 2007;18:1476\u20131485.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR31","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1007\/s00467-004-1573-2","volume":"19","author":"D Raveh","year":"2004","unstructured":"Raveh D, Shemesh O, Ashkenazi YJ, Winkler R, Barak V. Tumor necrosis factor-alpha blocking agent as a treatment for nephrotic syndrome. Pediatr Nephrol 2004;19:1281\u20131284.","journal-title":"Pediatr Nephrol"},{"key":"3_CR32","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1159\/000072065","volume":"23","author":"MH Cho","year":"2003","unstructured":"Cho MH, Lee HS, Choe BH, Kwon SH, Chung KY, Koo JH, et al. Interleukin-8 and tumor necrosis factor-alpha are increased in minimal change disease but do not alter albumin permeability. Am J Nephrol 2003;23:260\u2013266.","journal-title":"Am J Nephrol"},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1093\/ndt\/gfi180","volume":"20","author":"G Chin","year":"2005","unstructured":"Chin G, Luxton G, Harvey JM. Infliximab and nephrotic syndrome. Nephrol Dial Transplant 2005;20:2824\u20132826.","journal-title":"Nephrol Dial Transplant"},{"key":"3_CR34","doi-asserted-by":"crossref","first-page":"372304","DOI":"10.4061\/2011\/372304","volume":"2011","author":"JC Davin","year":"2011","unstructured":"Davin JC, Rutjes NW. Nephrotic syndrome in children: from bench to treatment. Int J Nephrol 2011;2011:372304.","journal-title":"Int J Nephrol"},{"key":"3_CR35","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s00467-008-1003-y","volume":"24","author":"Y Ikeuchi","year":"2009","unstructured":"Ikeuchi Y, Kobayashi Y, Arakawa H, Suzuki M, Tamra K, Morikawa A. Polymorphisms in interleukin-4-related genes in patients with minimal change nephrotic syndrome. Pediatr Nephrol 2009;24:489\u2013495.","journal-title":"Pediatr Nephrol"},{"key":"3_CR36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10157-010-0330-z","volume":"14","author":"T Kanai","year":"2010","unstructured":"Kanai T, Shiraishi H, Yamagata T, Ito T, Odaka J, Saito T, et al. Th2 cells predominate in idiopathic steroid-sensitive nephrotic syndrome. Clin Exp Nephrol 2010;14:578\u2013583.","journal-title":"Clin Exp Nephrol"},{"key":"3_CR37","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1042\/CS20040095","volume":"107","author":"JG Berg van den","year":"2004","unstructured":"van den Berg JG, Weening JJ. Role of the immune system in the pathogenesis of idiopathic nephrotic syndrome. Clin Sci (Lond) 2004;107:125\u2013136.","journal-title":"Clin Sci (Lond)"},{"key":"3_CR38","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S0140-6736(59)91026-8","volume":"1","author":"J Hardwicke","year":"1959","unstructured":"Hardwicke J, Soothill JF, Squire JR, Holti G. Nephrotic syndrome with pollen hypersensitivity. Lancet 1959;1:500\u2013502.","journal-title":"Lancet"},{"key":"3_CR39","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(70)90770-1","volume":"1","author":"HJ Wittig","year":"1970","unstructured":"Wittig HJ, Goldman AS. Nephrotic syndrome associated with inhaled allergens. Lancet 1970;1:542\u2013543.","journal-title":"Lancet"},{"key":"3_CR40","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1136\/adc.56.7.517","volume":"56","author":"SR Meadow","year":"1981","unstructured":"Meadow SR, Sarsfield JK, Scott DG, Rajah SM. Steroidresponsive nephrotic syndrome and allergy: immunological studies. Arch Dis Child 1981;56:517\u2013524.","journal-title":"Arch Dis Child"},{"key":"3_CR41","first-page":"601","volume":"61","author":"H Yokoyama","year":"1985","unstructured":"Yokoyama H, Kida H, Tani Y, Abe T, Tomosugi N, Koshino Y, et al. Immunodynamics of minimal change nephrotic syndrome in adults T and B lymphocyte subsets and serum immunoglobulin levels. Clin Exp Immunol 1985;61:601\u2013607.","journal-title":"Clin Exp Immunol"},{"key":"3_CR42","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/ajcp\/92.1.68","volume":"92","author":"BL Warshaw","year":"1989","unstructured":"Warshaw BL, Check IJ. IgG subclasses in children with nephrotic syndrome. Am J Clin Pathol 1989;92:68\u201372.","journal-title":"Am J Clin Pathol"},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1002\/eji.1830250604","volume":"25","author":"H Kimata","year":"1995","unstructured":"Kimata H, Fujimoto M, Furusho K. Involvement of interleukin (IL)-13, but not IL-4, in spontaneous IgE and IgG4 production in nephrotic syndrome. Eur J Immunol 1995;25:1497\u20131501.","journal-title":"Eur J Immunol"},{"key":"3_CR44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1007\/s00467-006-0026-5","volume":"21","author":"CE Araya","year":"2006","unstructured":"Araya CE, Wasserfall CH, Brusko TM, Mu W, Segal MS, Johnson RJ, et al. A case of unfulfilled expectations. Cytokines in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2006;21:603\u2013610.","journal-title":"Pediatr Nephrol"},{"key":"3_CR45","doi-asserted-by":"crossref","first-page":"393","DOI":"10.5414\/CNP58393","volume":"58","author":"K Kaneko","year":"2002","unstructured":"Kaneko K, Tuchiya K, Fujinaga S, Kawamura R, Ohtomo Y, Shimizu T, et al. Th1\/Th2 balance in childhood idiopathic nephrotic syndrome. Clin Nephrol 2002;58:393\u2013397.","journal-title":"Clin Nephrol"},{"key":"3_CR46","doi-asserted-by":"crossref","first-page":"2751","DOI":"10.1056\/NEJMc063706","volume":"356","author":"A Bagga","year":"2007","unstructured":"Bagga A, Sinha A, Moudgil A. Rituximab in patients with the steroid-resistant nephrotic syndrome. N Engl J Med 2007;356:2751\u20132752.","journal-title":"N Engl J Med"},{"key":"3_CR47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00467-007-0596-x","volume":"23","author":"J Dotsch","year":"2008","unstructured":"Dotsch J, Muller-Wiefel DE, Kemper MJ. Rituximab: is replacement of cyclophosphamide and calcineurin inhibitors in steroid-dependent nephrotic syndrome possible? Pediatr Nephrol 2008;23:3\u20137.","journal-title":"Pediatr Nephrol"},{"key":"3_CR48","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1159\/000356439","volume":"38","author":"T Kimata","year":"2013","unstructured":"Kimata T, Hasui M, Kino J, Kitao T, Yamanouchi S, Tsuji S, et al. Novel use of rituximab for steroid-dependent nephrotic syndrome in children. Am J Nephrol 2013;38:483\u2013488.","journal-title":"Am J Nephrol"},{"key":"3_CR49","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00467-008-1092-7","volume":"24","author":"A Iharada","year":"2009","unstructured":"Iharada A, Kaneko K, Tsuji S, Hasui M, Kanda S, Nishiyama T. Increased nitric oxide production by T- and B-cells in idiopathic nephrotic syndrome. Pediatr Nephrol 2009;24:1033\u20131038.","journal-title":"Pediatr Nephrol"},{"key":"3_CR50","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S1097-2765(00)80057-X","volume":"1","author":"M Kestila","year":"1998","unstructured":"Kestila M, Lenkkeri U, M\u00e4nnikk\u00f6 M, Lamerdin J, McCready P, Putaala H, et al. Positionally cloned gene for a novel glomerular protein\u2014nephrin\u2014is mutated in congenital nephrotic syndrome. Mol Cell 1998;1:575\u2013582.","journal-title":"Mol Cell"},{"key":"3_CR51","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1172\/JCI20402","volume":"113","author":"J Reiser","year":"2004","unstructured":"Reiser J, von Gersdorff G, Loos M, Oh J, Asanuma K, Giardino L, et al. Induction of B7-1 in podocytes is associated with nephrotic syndrome. J Clin Invest 2004;113:1390\u20131397.","journal-title":"J Clin Invest"},{"key":"3_CR52","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1053\/j.ajkd.2011.07.024","volume":"59","author":"SS Chugh","year":"2012","unstructured":"Chugh SS, Clement LC, Mace C. New insights into human minimal change disease: lessons from animal models. Am J Kidney Dis 2012;59:284\u2013292.","journal-title":"Am J Kidney Dis"},{"key":"3_CR53","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00467-010-1676-x","volume":"26","author":"M Shimada","year":"2011","unstructured":"Shimada M, Araya C, Rivard C, Ishimoto T, Johnson RJ, Garin EH. Minimal change disease: a \u201ctwo-hit\u201d podocyte immune disorder? Pediatr Nephrol 2011;26:645\u2013649.","journal-title":"Pediatr Nephrol"},{"key":"3_CR54","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1007\/s00467-012-2376-5","volume":"28","author":"I Simic","year":"2013","unstructured":"Simic I, Tabatabaeifar M, Schaefer F. Animal models of nephrotic syndrome. Pediatr Nephrol 2013;28:2079\u20132088.","journal-title":"Pediatr Nephrol"},{"key":"3_CR55","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1097\/00041552-200107000-00009","volume":"10","author":"K Tryggvason","year":"2001","unstructured":"Tryggvason K, Wartiovaara J. Molecular basis of glomerular permselectivity. Curr Opin Nephrol Hypertens 2001;10:543\u2013549.","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"3_CR56","first-page":"673","volume":"59","author":"D Drenckhahn","year":"1988","unstructured":"Drenckhahn D, Franke RP. Ultrastructural organization of contractile and cytoskeletal proteins in glomerular podocytes of chicken, rat, and man. Lab Invest 1988;59:673\u2013682.","journal-title":"Lab Invest"},{"key":"3_CR57","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1177\/39.8.1856454","volume":"39","author":"P Mundel","year":"1991","unstructured":"Mundel P, Gilbert P, Kriz W. Podocytes in glomerulus of rat kidney express a characteristic 44 KD protein. J Histochem Cytochem 1991;39:1047\u20131056.","journal-title":"J Histochem Cytochem"},{"key":"3_CR58","first-page":"571","volume":"141","author":"S Adler","year":"1992","unstructured":"Adler S. Characterization of glomerular epithelial cell matrix receptors. Am J Pathol 1992;141:571\u2013578.","journal-title":"Am J Pathol"},{"key":"3_CR59","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1681\/ASN.V113403","volume":"11","author":"HM Regele","year":"2000","unstructured":"Regele HM, Fillipovic E, Langer B, Poczewki H, Kraxberger I, Bittner RE, et al. Glomerular expression of dystroglycans is reduced in minimal change nephrosis but not in focal segmental glomerulosclerosis. J Am Soc Nephrol 2000;11:403\u2013412.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR60","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1093\/ndt\/18.1.70","volume":"18","author":"A Wernerson","year":"2003","unstructured":"Wernerson A, Duner F, Pettersson E, Widholm SM, Berg U, Ruotsalainen V, et al. Altered ultrastructural distribution of nephrin in minimal change nephrotic syndrome. Nephrol Dial Transplant 2003;18:70\u201376.","journal-title":"Nephrol Dial Transplant"},{"key":"3_CR61","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00467-003-1346-3","volume":"19","author":"SR Hingorani","year":"2004","unstructured":"Hingorani SR, Finn LS, Kowalewska J, McDonald RA, Eddy AA. Expression of nephrin in acquired forms of nephrotic syndrome in childhood. Pediatr Nephrol 2004;19:300\u2013305.","journal-title":"Pediatr Nephrol"},{"key":"3_CR62","doi-asserted-by":"crossref","first-page":"481520","DOI":"10.1155\/2012\/481520","volume":"2012","author":"A Tojo","year":"2012","unstructured":"Tojo A, Kinugasa S. Mechanisms of glomerular albumin filtration and tubular reabsorption. Int J Nephrol 2012;2012:481520.","journal-title":"Int J Nephrol"},{"key":"3_CR63","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1097\/01.ASN.0000139478.03463.D9","volume":"15","author":"AT Lahdenkari","year":"2004","unstructured":"Lahdenkari AT, Lounatmaa K, Patrakka J, Holmberg C, Wartiovaara J, Kestila M, et al. Podocytes are firmly attached to glomerular basement membrane in kidneys with heavy proteinuria. J Am Soc Nephrol 2004;15:2611\u20132618.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fphar.2014.00023","volume":"5","author":"SS Chugh","year":"2014","unstructured":"Chugh SS, Mace C, Clement LC, Del Nogal Avila M, Marshall CB. Angiopoietin-like 4 based therapeutics for proteinuria and kidney disease. Front Pharmacol 2014;5:23.","journal-title":"Front Pharmacol"},{"key":"3_CR65","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/nm.2261","volume":"17","author":"LC Clement","year":"2011","unstructured":"Clement LC, Avila-Casado C, Mace C, Soria E, Bakker WW, Kersten S, et al. Podocyte-secreted angiopoietin-like-4 mediates proteinuria in glucocorticoid-sensitive nephrotic syndrome. Nat Med 2011;17:117\u2013122.","journal-title":"Nat Med"},{"key":"3_CR66","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1681\/ASN.2007080836","volume":"20","author":"EH Garin","year":"2009","unstructured":"Garin EH, Diaz LN, Mu W, Wasserfall C, Araya C, Segal M, et al. Urinary CD80 excretion increases in idiopathic minimalchange disease. J Am Soc Nephrol 2009;20:260\u2013266.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR67","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1038\/ki.2010.143","volume":"78","author":"EH Garin","year":"2010","unstructured":"Garin EH, Mu W, Arthur JM, Rivard CJ, Araya CE, Shimada M, et al. Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis. Kidney Int 2010;78:296\u2013302.","journal-title":"Kidney Int"},{"key":"3_CR68","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1007\/s00467-013-2498-4","volume":"28","author":"T Ishimoto","year":"2013","unstructured":"Ishimoto T, Cara-Fuentes G, Wang H, Shimada M, Wasserfall CH, Winter WE, et al. Serum from minimal change patients in relapse increases CD80 expression in cultured podocytes. Pediatr Nephrol 2013;28:1803\u20131812.","journal-title":"Pediatr Nephrol"},{"key":"3_CR69","first-page":"ra39","volume":"3","author":"SY Zhang","year":"2010","unstructured":"Zhang SY, Kamal M, Dahan K, Pawlak A, Ory V, Desvaux D, et al. c-mip impairs podocyte proximal signaling and induces heavy proteinuria. Sci Signal 2010;3:ra39.","journal-title":"Sci Signal"},{"key":"3_CR70","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1126\/science.1160062","volume":"322","author":"K Wing","year":"2008","unstructured":"Wing K, Onishi Y, Prieto-Martin P, Yamaguchi T, Miyara M, Fehervari Z, et al. CTLA-4 control over Foxp3+ regulatory T cell function. Science 2008;322:271\u2013275.","journal-title":"Science"},{"key":"3_CR71","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1093\/ndt\/gfr271","volume":"27","author":"M Shimada","year":"2012","unstructured":"Shimada M, Ishimoto T, Lee PY, Lanaspa MA, Rivard CJ, Roncal-Jimenez CA, et al. Toll-like receptor 3 ligands induce CD80 expression in human podocytes via an NF-kappaBdependent pathway. Nephrol Dial Transplant 2012;27:81\u201389.","journal-title":"Nephrol Dial Transplant"},{"key":"3_CR72","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/j.1440-1754.2004.00285.x","volume":"40","author":"RK Alwadhi","year":"2004","unstructured":"Alwadhi RK, Mathew JL, Rath B. Clinical profile of children with nephrotic syndrome not on glucorticoid therapy, but presenting with infection. J Paediatr Child Health 2004;40:28\u201332.","journal-title":"J Paediatr Child Health"},{"key":"3_CR73","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1600-065X.2008.00706.x","volume":"226","author":"DM Mosser","year":"2008","unstructured":"Mosser DM, Zhang X. Interleukin-10: new perspectives on an old cytokine. Immunol Rev 2008;226:205\u2013218.","journal-title":"Immunol Rev"},{"key":"3_CR74","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1007\/s00467-009-1214-x","volume":"24","author":"C Araya","year":"2009","unstructured":"Araya C, Diaz L, Wasserfall C, Atkinson M, Mu W, Johnson R, et al. T regulatory cell function in idiopathic minimal lesion nephrotic syndrome. Pediatr Nephrol 2009;24:1691\u20131698.","journal-title":"Pediatr Nephrol"},{"key":"3_CR75","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.clim.2011.02.018","volume":"139","author":"LL Liu","year":"2011","unstructured":"Liu LL, Qin Y, Cai JF, Wang HY, Tao JL, Li H, et al. Th17\/Treg imbalance in adult patients with minimal change nephrotic syndrome. Clin Immunol 2011;139:314\u2013320.","journal-title":"Clin Immunol"},{"key":"3_CR76","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.autrev.2013.01.001","volume":"12","author":"M Cutolo","year":"2013","unstructured":"Cutolo M, Nadler SG. Advances in CTLA-4-Ig-mediated modulation of inflammatory cell and immune response activation in rheumatoid arthritis. Autoimmun Rev 2013;12:758\u2013767.","journal-title":"Autoimmun Rev"},{"key":"3_CR77","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/nm.3396","volume":"20","author":"LC Clement","year":"2014","unstructured":"Clement LC, Mace C, Avila-Casado C, Joles JA, Kersten S, Chugh SS. Circulating angiopoietin-like 4 links proteinuria with hypertriglyceridemia in nephrotic syndrome. Nat Med 2014;20:37\u201346.","journal-title":"Nat Med"},{"key":"3_CR78","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1194\/jlr.C200010-JLR200","volume":"43","author":"K Yoshida","year":"2002","unstructured":"Yoshida K, Shimizugawa T, Ono M, Furukawa H. Angiopoietinlike protein 4 is a potent hyperlipidemia-inducing factor in mice and inhibitor of lipoprotein lipase. J Lipid Res 2002;43:1770\u20131772.","journal-title":"J Lipid Res"},{"key":"3_CR79","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1093\/ndt\/gft381","volume":"28","author":"C Spink","year":"2013","unstructured":"Spink C, Stege G, Tenbrock K, Harendza S. The CTLA-4 +49GG genotype is associated with susceptibility for nephrotic kidney diseases. Nephrol Dial Transplant 2013;28:2800\u20132805.","journal-title":"Nephrol Dial Transplant"},{"key":"3_CR80","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1016\/j.bbrc.2009.12.145","volume":"391","author":"B Lu","year":"2010","unstructured":"Lu B, Moser A, Shigenaga JK, Grunfeld C, Feingold KR. The acute phase response stimulates the expression of angiopoietin like protein 4. Biochem Biophys Res Commun 2010;391:1737\u20131741.","journal-title":"Biochem Biophys Res Commun"},{"key":"3_CR81","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ndt\/gfq617","volume":"26","author":"E Schonenberger","year":"2011","unstructured":"Schonenberger E, Ehrich JH, Haller H, Schiffer M. The podocyte as a direct target of immunosuppressive agents. Nephrol Dial Transplant 2011;26:18\u201324.","journal-title":"Nephrol Dial Transplant"},{"key":"3_CR82","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrneph.2011.171","volume":"8","author":"PW Mathieson","year":"2012","unstructured":"Mathieson PW. The podocyte as a target for therapies\u2014new and old. Nat Rev Nephrol 2012;8:52\u201356.","journal-title":"Nat Rev Nephrol"},{"key":"3_CR83","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.ki.5001655","volume":"70","author":"CY Xing","year":"2006","unstructured":"Xing CY, Saleem MA, Coward RJ, Ni L, Witherden IR, Mathieson PW. Direct effects of dexamethasone on human podocytes. Kidney Int 2006;70:1038\u20131045.","journal-title":"Kidney Int"},{"key":"3_CR84","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1681\/ASN.2008111219","volume":"20","author":"S Hussain","year":"2009","unstructured":"Hussain S, Romio L, Saleem M, Mathieson P, Serrano M, Moscat J, et al. Nephrin deficiency activates NF-kappaB and promotes glomerular injury. J Am Soc Nephrol 2009;20:1733\u20131743.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR85","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000348803","volume":"37","author":"T Shimo","year":"2013","unstructured":"Shimo T, Adachi Y, Yamanouchi S, Tsuji S, Kimata T, Umezawa K, et al. A novel nuclear factor kappaB inhibitor, dehydroxymethylepoxyquinomicin, ameliorates puromycin aminonucleoside-induced nephrosis in mice. Am J Nephrol 2013;37:302\u2013309.","journal-title":"Am J Nephrol"},{"key":"3_CR86","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1038\/nm.1857","volume":"14","author":"C Faul","year":"2008","unstructured":"Faul C, Donnelly M, Merscher-Gomez S, Chang YH, Franz S, Delfgaauw J, et al. The actin cytoskeleton of kidney podocytes is a direct target of the antiproteinuric effect of cyclosporine A. Nat Med 2008;14:931\u2013938.","journal-title":"Nat Med"},{"key":"3_CR87","doi-asserted-by":"crossref","first-page":"85ra46","DOI":"10.1126\/scitranslmed.3002231","volume":"3","author":"A Fornoni","year":"2011","unstructured":"Fornoni A, Sageshima J, Wei C, Merscher-Gomez S, Aguillon-Prada R, Jauregui AN, et al. Rituximab targets podocytes in recurrent focal segmental glomerulosclerosis. Sci Transl Med 2011;3:85ra46.","journal-title":"Sci Transl Med"},{"key":"3_CR88","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1056\/NEJMoa1304572","volume":"369","author":"CC Yu","year":"2013","unstructured":"Yu CC, Fornoni A, Weins A, Hakroush S, Maiguel D, Sageshima J, et al. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 2013;369:2416\u20132423.","journal-title":"N Engl J Med"},{"key":"3_CR89","first-page":"1263","volume":"370","author":"N Alachkar","year":"2014","unstructured":"Alachkar N, Carter-Monroe N, Reiser J. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 2014;370:1263\u20131264.","journal-title":"N Engl J Med"},{"key":"3_CR90","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1056\/NEJMc1400502","volume":"370","author":"A Benigni","year":"2014","unstructured":"Benigni A, Gagliardini E, Remuzzi G. Abatacept in B7-1-positive proteinuric kidney disease. N Engl J Med 2014;370:1261\u20131263.","journal-title":"N Engl J Med"},{"key":"3_CR91","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1681\/ASN.V1281648","volume":"12","author":"D Sahali","year":"2001","unstructured":"Sahali D, Pawlak A, Le Gouvello S, Lang P, Valanciute A, Remy P, et al. Transcriptional and post-transcriptional alterations of IkappaBalpha in active minimal-change nephrotic syndrome. J Am Soc Nephrol 2001;12:1648\u20131658.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR92","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1681\/ASN.2007080940","volume":"19","author":"R Lennon","year":"2008","unstructured":"Lennon R, Singh A, Welsh GI, Coward RJ, Satchell S, Ni L, et al. Hemopexin induces nephrin-dependent reorganization of the actin cytoskeleton in podocytes. J Am Soc Nephrol 2008;19:2140\u20132149.","journal-title":"J Am Soc Nephrol"},{"key":"3_CR93","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.2215\/CJN.03800609","volume":"5","author":"ET McCarthy","year":"2010","unstructured":"McCarthy ET, Sharma M, Savin VJ. Circulating permeability factors in idiopathic nephrotic syndrome and focal segmental glomerulosclerosis. Clin J Am Soc Nephrol 2010;5:2115\u20132121.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3_CR94","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1365-2249.2010.04160.x","volume":"161","author":"R Bertelli","year":"2010","unstructured":"Bertelli R, Trivelli A, Magnasco A, Cioni M, Bodria M, Carrea A, et al. Failure of regulation results in an amplified oxidation burst by neutrophils in children with primary nephrotic syndrome. Clin Exp Immunol 2010;161:151\u2013158.","journal-title":"Clin Exp Immunol"},{"key":"3_CR95","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1007\/s00467-013-2679-1","volume":"29","author":"G Cara-Fuentes","year":"2014","unstructured":"Cara-Fuentes G, Wei C, Segarra A, Ishimoto T, Rivard C, Johnson RJ, et al. CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance. Pediatr Nephrol 2014;29:1363\u20131371.","journal-title":"Pediatr Nephrol"},{"key":"3_CR96","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1093\/ndt\/gfs543","volume":"28","author":"T Ishimoto","year":"2013","unstructured":"Ishimoto T, Shimada M, Gabriela G, Kosugi T, Sato W, Lee PY, et al. Toll-like receptor 3 ligand, polyIC, induces proteinuria and glomerular CD80, and increases urinary CD80 in mice. Nephrol Dial Transplant 2013;28:1439\u20131446.","journal-title":"Nephrol Dial Transplant"},{"key":"3_CR97","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.2215\/CJN.01190210","volume":"5","author":"AK B\u00fcscher","year":"2010","unstructured":"B\u00fcscher AK, Kranz B, B\u00fcscher R, Hildebrandt F, Dworniczak B, Pennekamp P, et al. Immunosuppression and renal outcome in congenital and pediatric steroid-resistant nephrotic syndrome. Clin J Am Soc Nephrol 2010;5:2075\u20132084.","journal-title":"Clin J Am Soc Nephrol"},{"key":"3_CR98","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1038\/ncprheum0983","volume":"5","author":"SK Datta","year":"2009","unstructured":"Datta SK. Anti-CD20 antibody is an efficient therapeutic tool for the selective removal of autoreactive T cells. Nat Clin Pract Rheumatol 2009;5:80\u201382.","journal-title":"Nat Clin Pract Rheumatol"}],"container-title":["World Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-015-0003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12519-015-0003-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12519-015-0003-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,27]],"date-time":"2022-04-27T17:38:03Z","timestamp":1651081083000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12519-015-0003-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,28]]},"references-count":98,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1007\/s12519-015-0003-9","relation":{},"ISSN":["1708-8569","1867-0687"],"issn-type":[{"value":"1708-8569","type":"print"},{"value":"1867-0687","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,28]]}}}